EQUIFAX INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data EQUIFAX INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,145	3,362	3,412	3,508	4,128	4,924	5,122	5,265	5,681	6,075
Cost of revenue	1,113	1,211	1,440	1,522	1,737	1,981	2,177	2,335	2,519	2,646
Gross profit	2,032	2,152	1,972	1,986	2,390	2,943	2,945	2,930	3,162	3,429
Selling, general and administrative	941	1,032	1,213	1,990	1,323	1,325	1,329	1,386	1,451	1,614
Operating income	825	832	448	-335	677	1,138	1,056	934	1,042	1,095
Interest expense	92.1	92.8	104	112	142	146	183	241	229	212
Other non-operating income	-4.8	7.7	25.9	33.3	150	-43.2	56.7	25.7	-2.5	12
Pre-tax income	728	747	370	-414	685	949	930	718	811	895
Income tax	233	149	53.4	-35.7	159	201	230	166	203	231
Net income to minority interests	6.3	10.7	6.5	6	6.1	4.3	4	6.4	3.2	4
Net income	489	587	311	-384	520	744	696	545	604	660
EBITDA	1,094	1,123	764	1.9	1,076	1,628	1,625	1,553	1,723	1,822
EPS, basic	4.10	4.89	2.58	-3.18	4.28	6.11	5.69	4.44	4.88	5.36
EPS, diluted	4.04	4.83	2.56	-3.15	4.24	6.02	5.65	4.40	4.84	5.32
Shares, basic (weighted)	119	120	120	121	122	122	122	123	124	123
Shares, diluted (weighted)	121	122	121	122	123	124	123	124	125	124
Dividend per share	1.32	1.56	1.56	1.56	1.56	1.56	1.56	1.56	1.56	1.89

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	129	336	224	401	1,685	225	285	217	170	181
Receivables	433	445	469	532	631	728	858	908	958	1,013
Other current assets	50.1	123	110	188	59	60.2	93.3	88.8	98.2	74.5
Total current assets	673	998	902	1,209	2,478	1,121	1,371	1,356	1,361	1,412
Property, plant and equipment	467	567	765	948	1,139	1,316	1,587	1,834	1,892	1,932
Goodwill	3,974	4,184	4,130	4,308	4,496	6,258	6,384	6,830	6,548	6,746
Intangible assets	1,324	1,247	1,099	1,045	998	1,898	1,819	1,859	1,521	1,331
Other non-current assets	131	142	162	304	406	353	293	306	343	348
Total assets	6,664	7,233	7,153	7,909	9,612	11,041	11,548	12,280	11,759	11,864
Accounts payable	81	110	176	148	159	212	251	198	138	206
Accrued liabilities	149	161	213	164	252	238	229	245	251	276
Deferred revenue	111	108	98	104	108	121	133	110	116	101
Short-term debt	585	965	4.9	3.1	1,101	825	967	963	688	1,038
Total current liabilities	1,260	1,674	827	1,359	2,483	2,291	2,015	2,019	1,812	2,335
Long-term debt	2,087	1,739	2,631	3,380	3,277	4,470	4,820	4,748	4,323	4,055
Other non-current liabilities	86.5	101	84.6	181	178	190	179	251	247	241
Total liabilities	3,943	3,994	3,998	5,286	6,402	7,440	7,575	7,593	6,840	7,126
Total debt	2,685	2,715	2,655	3,403	4,402	5,325	5,817	5,742	5,038	5,114
Paid-in capital	1,313	1,333	1,357	1,405	1,471	1,537	1,594	1,761	1,915	2,023
Retained earnings	4,153	4,601	4,718	3,855	4,185	4,752	5,256	5,609	6,019	6,445
Treasury stock	-2,506	-2,578	-2,571	-2,557	-2,547	-2,639	-2,651	-2,635	-2,645	-3,578
Other comprehensive income	-529	-412	-335	-354	-171	-295	-474	-431	-723	-517
Shareholders' equity	2,663	3,174	3,108	2,579	3,168	3,584	3,957	4,534	4,797	4,604
Minority interests	58.6	64.6	47.9	44.3	41.9	16.8	16.8	18.3	17.5	19.5
Total equity	2,721	3,239	3,156	2,623	3,210	3,601	3,973	4,552	4,814	4,624
Total liabilities and equity	6,664	7,233	7,153	7,909	9,612	11,041	11,548	12,280	11,759	11,864
Shares outstanding	120	120	121	121	122	122	123	123	124	120

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	495	598	317	-378	526	749	700	552	607	664
Depreciation and amortization	269	291	316	337	399	490	569	620	681	727
Stock-based compensation	37.1	38.3	42.5	49.7	54.7	54.9	62.6	71.8	81.6	78.4
Deferred income tax	-13	-44.1	1.5	-82.7	66.5	9.3	88.1	-70.2	-66.9	30.2
Change in receivables	-55.7	-1.3	-37.4	-61.3	-93.7	-66.2	-139	-23.3	-66.3	-40.9
Cash from operations	823	816	672	314	946	1,335	757	1,117	1,325	1,616
Capital expenditures	-174	-218	-322	-400	-421	-469	-625	-601	-512	-481
Acquisitions	-1,792	-140	-138	-273	-61.4	-2,936	-434	-284	0	-74.1
Cash from investing	-1,976	-350	-462	-698	-493	-3,398	-960	-878	-512	-554
Debt issued	1,575	100	995	998	1,123	1,697	749	873	650	1.7
Debt repaid	-350	-323	-100	-250	-125	-1,100	-500	-579	-1,446	-400
Stock issued	31.5	19.2	11.8	22.3	41.7	46.8	16.9	32.3	78.2	46.4
Share buybacks	0	-77.1	0	0	0	-69.9	0	0	0	-928
Dividends paid	-158	-187	-188	-189	-190	-190	-191	-192	-193	-233
Cash from financing	1,160	-264	-311	558	811	618	274	-306	-846	-1,060
Exchange rate effect	28.6	4.3	-12.5	3.5	19	-14.2	-10.8	-0.8	-13.5	9.2
Net change in cash	36	207	-113	178	1,283	-1,460	60.5	-68.4	-46.9	10.9
Free cash flow	650	598	350	-85.8	525	866	133	516	813	1,134
Interest paid	85	96.9	88.2	105	131	140	162	232	215	210
Income taxes paid	173	216	59.6	12	75.6	192	152	203	268	198

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $148.11 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	55.5%	Gross profit / revenue.
Operating margin	17.9%	Operating income / revenue.
EBITDA margin	29.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	14.6%	Pre-tax income / revenue.
Net margin	10.7%	Net income / revenue.
FCF margin	17.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	25.0%	Cash from operations / revenue.
Effective tax rate	26.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	15.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	5.8%	Net income / average total assets.
Return on invested capital (ROIC)	10.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	26.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	7.9%	Capital expenditures / revenue.
D&A / revenue	11.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	6.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	8.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	8.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	5.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	7.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	5.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	1.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	10.1%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	5.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	3.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	11.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	9.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-1.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	4.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	9.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-2.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	4.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	22.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	28.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	11.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	39.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	104.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	16.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	21.2%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	6.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	3.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-4.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	5.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	7.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	4.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.60x	Current assets / current liabilities.
Quick ratio	0.49x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.06x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.93x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	33.9%	Total debt / total assets.
Liabilities / assets	62.3%	Total liabilities / total assets.
Net debt	$3.89B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.05x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	5.19x	Operating income / interest expense.
Working capital	-$1.04B	Current assets - current liabilities.
Goodwill and intangibles / assets	66.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$3.64B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.54x	Revenue / average total assets.
Fixed asset turnover	3.34x	Revenue / average property, plant and equipment.
Receivables turnover	5.84x	Revenue / average receivables.
Days sales outstanding	63 days	365 x average receivables / revenue.
Days payables	16 days	365 x average accounts payable / cost of revenue.
FCF conversion	159.8%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	31.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.80	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$54.06	Revenue / diluted weighted shares.
FCF per share	$9.27	Free cash flow / diluted weighted shares.
Operating cash flow per share	$13.53	Cash from operations / diluted weighted shares.
Book value per share	$37.25	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$30.93	Tangible book value / shares outstanding.
Cash per share	$1.45	(Cash + short-term investments) / shares outstanding.
Payout ratio	37.0%	Dividends paid / net income, when net income is positive.
Dividends / FCF	23.1%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	123.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$17.40B	Share price x shares outstanding.
Enterprise value	$21.29B	Market cap + total debt - cash - short-term investments.
P/E	25.2x	Market cap / net income. Only when net income is positive.
P/S	2.70x	Market cap / revenue.
P/B	3.97x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	15.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	10.8x	Market cap / cash from operations, when positive.
EV/Sales	3.30x	Enterprise value / revenue.
EV/EBIT	18.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	19.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.4%	Free cash flow / market cap.
Earnings yield	4.0%	Net income / market cap (the inverse of P/E).
Dividend yield	1.5%	Dividends paid over the period / market cap.
Shareholder yield	9.3%	(Dividends paid + share buybacks) / market cap.

What was EQUIFAX INC's revenue in fiscal 2025?

EQUIFAX INC reported revenue of $6.07B for fiscal 2025, 6.9% higher than the year before.

Was EQUIFAX INC profitable in fiscal 2025?

Yes. Net income was $660.3M, a net margin of 10.9%.

How much free cash flow did EQUIFAX INC generate in fiscal 2025?

Cash from operations of $1.62B minus capital expenditures of $481.4M left free cash flow of $1.13B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to EQUIFAX INC